Incepta’s Vaccine Ambitions Bridled By Bangladesh Regulatory Gap
This article was originally published in PharmAsia News
Executive Summary
Bangladesh's Incepta Vaccine is gearing up for a larger play with vaccines for pneumonia and human papillomavirus in the pipeline, but a non-functional national regulatory authority in the country could stymie its ambitions in terms of large-scale supplies of other products to Unicef, at least in the short-term.